Profound Medical Corp (PRN) - Total Liabilities

Latest as of March 2026: CA$19.58 Million CAD ≈ $14.17 Million USD

Based on the latest financial reports, Profound Medical Corp (PRN) has total liabilities worth CA$19.58 Million CAD (≈ $14.17 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Profound Medical Corp - Total Liabilities Trend (2014–2025)

This chart illustrates how Profound Medical Corp's total liabilities have evolved over time, based on quarterly financial data. See PRN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Profound Medical Corp Competitors by Total Liabilities

The table below lists competitors of Profound Medical Corp ranked by their total liabilities.

Company	Country	Total Liabilities
SILENCE THERAP. SP.ADR/1 F:XRP2	Germany	€69.14 Million
Light S.A SA:LIGT3	Brazil	R$20.12 Billion
Innoprise Plantations Bhd KLSE:6262	Malaysia	RM98.25 Million
Global Tax Free Co. Ltd KQ:204620	Korea	₩53.72 Billion
Ingevec SN:INGEVEC	Chile	CL$216.22 Billion
Mitra Pinasthika Mustika Tbk JK:MPMX	Indonesia	Rp2.94 Trillion
HengFeng Information Technology Co Ltd SHE:300605	China	CN¥835.86 Million
Huuuge Inc. WAR:HUG	Poland	zł21.78 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Profound Medical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Profound Medical Corp market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.56	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Profound Medical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Profound Medical Corp (2014–2025)

The table below shows the annual total liabilities of Profound Medical Corp from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	CA$102.04 Million ≈ $73.81 Million	+939.91%
2024-12-31	CA$9.81 Million ≈ $7.10 Million	-22.93%
2023-12-31	CA$12.73 Million ≈ $9.21 Million	+2.53%
2022-12-31	CA$12.42 Million ≈ $8.98 Million	+101.67%
2021-12-31	CA$6.16 Million ≈ $4.45 Million	-15.09%
2020-12-31	CA$7.25 Million ≈ $5.25 Million	-53.52%
2019-12-31	CA$15.60 Million ≈ $11.28 Million	+6.65%
2018-12-31	CA$14.63 Million ≈ $10.58 Million	+33.89%
2017-12-31	CA$10.93 Million ≈ $7.90 Million	+65.80%
2016-12-31	CA$6.59 Million ≈ $4.77 Million	+26.55%
2015-12-31	CA$5.21 Million ≈ $3.77 Million	+4968.41%
2014-12-31	CA$102.73K ≈ $74.31K	--

About Profound Medical Corp

TO:PRN Canada Medical Devices

Market Cap

$245.21 Million

CA$338.98 Million CAD

Market Cap Rank

#15827 Global

#477 in Canada

Share Price

CA$9.34

Change (1 day)

-2.20%

52-Week Range

CA$5.35 - CA$12.11

All Time High

CA$35.63